| Community infections caused by extended-spectrum β-lactamase–producing Escherichia coli J Rodríguez-Baño, JC Alcalá, JM Cisneros, F Grill, A Oliver, JP Horcajada, ... Archives of internal medicine 168 (17), 1897-1902, 2008 | 567 | 2008 |
| Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis J Rodríguez-Baño, E Picón, P Gijón, JR Hernández, M Ruíz, C Pena, ... Clinical infectious diseases 50 (1), 40-48, 2010 | 459 | 2010 |
| Detection of heteromerization of more than two proteins by sequential BRET-FRET P Carriba, G Navarro, F Ciruela, S Ferré, V Casadó, L Agnati, A Cortés, ... Nature methods 5 (8), 727-733, 2008 | 353 | 2008 |
| Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli J Rodríguez-Bano, E Picón, P Gijón, JR Hernández, JM Cisneros, C Pena, ... Journal of clinical microbiology 48 (5), 1726-1731, 2010 | 230 | 2010 |
| The Minnesota living with heart failure questionnaire: comparison of different factor structures A Bilbao, A Escobar, L García-Perez, G Navarro, R Quirós Health and quality of life outcomes 14, 1-11, 2016 | 218 | 2016 |
| Validation of the Spanish version of the Lawton IADL Scale for its application in elderly people I Vergara, A Bilbao, M Orive, S Garcia-Gutierrez, G Navarro, JM Quintana Health and quality of life outcomes 10, 1-7, 2012 | 218 | 2012 |
| Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors X Viñals, E Moreno, L Lanfumey, A Cordomí, A Pastor, R de La Torre, ... PLoS biology 13 (7), e1002194, 2015 | 210 | 2015 |
| Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine G Navarro, E Moreno, M Aymerich, D Marcellino, PJ McCormick, J Mallol, ... Proceedings of the National Academy of Sciences 107 (43), 18676-18681, 2010 | 185 | 2010 |
| Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors E Martínez-Pinilla, K Varani, I Reyes-Resina, E Angelats, F Vincenzi, ... Frontiers in pharmacology 8, 290777, 2017 | 183 | 2017 |
| Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer J Bonaventura, G Navarro, V Casadó-Anguera, K Azdad, W Rea, ... Proceedings of the National Academy of Sciences 112 (27), E3609-E3618, 2015 | 163 | 2015 |
| Adenosine–cannabinoid receptor interactions. Implications for striatal function S Ferré, C Lluís, Z Justinova, C Quiroz, M Orru, G Navarro, EI Canela, ... British journal of pharmacology 160 (3), 443-453, 2010 | 161 | 2010 |
| Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more MM Nogueras, G Navarro, E Antón, M Sala, M Cervantes, MJ Amengual, ... BMC infectious diseases 6, 1-9, 2006 | 159 | 2006 |
| Detection of Heteromers Formed by Cannabinoid CB1, Dopamine D2, and Adenosine A2A G-Protein-Coupled Receptors by Combining Bimolecular … G Navarro, P Carriba, J Gandí, F Ciruela, V Casadó, A Cortés, J Mallol, ... The Scientific World Journal 8, 1088-1097, 2008 | 155 | 2008 |
| A1R–A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes S Cristóvão-Ferreira, G Navarro, M Brugarolas, K Pérez-Capote, SH Vaz, ... Purinergic signalling 9, 433-449, 2013 | 151 | 2013 |
| Basic pharmacological and structural evidence for class A G-protein-coupled receptor heteromerization R Franco, E Martínez-Pinilla, JL Lanciego, G Navarro Frontiers in pharmacology 7, 181687, 2016 | 148 | 2016 |
| Targeting cannabinoid CB2 receptors in the central nervous system. Medicinal chemistry approaches with focus on neurodegenerative disorders G Navarro, P Morales, C Rodríguez-Cueto, J Fernández-Ruiz, ... Frontiers in Neuroscience 10, 211100, 2016 | 144 | 2016 |
| Cocaine Inhibits Dopamine D2 Receptor Signaling via Sigma-1-D2 Receptor Heteromers G Navarro, E Moreno, J Bonaventura, M Brugarolas, D Farre, D Aguinaga, ... PloS one 8 (4), e61245, 2013 | 142 | 2013 |
| Functional selectivity of allosteric interactions within G protein–coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer X Guitart, G Navarro, E Moreno, H Yano, NS Cai, M Sánchez-Soto, ... Molecular pharmacology 86 (4), 417-429, 2014 | 138 | 2014 |
| Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway E Moreno, H Hoffmann, M Gonzalez-Sepulveda, G Navarro, V Casado, ... Journal of biological chemistry 286 (7), 5846-5854, 2011 | 136 | 2011 |
| Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers G Navarro, S Ferré, A Cordomi, E Moreno, J Mallol, V Casadó, A Cortés, ... Journal of Biological Chemistry 285 (35), 27346-27359, 2010 | 131 | 2010 |
